Smart Ring Maker Oura Files to Go Public: What It Means

Smart ring maker Oura has officially filed to go public, putting the Finnish health wearable company squarely in the spotlight for investors and the broader tech industry. With 5.5 million devices sold to date, this isn't a startup chasing a valuation on vibes — it's a company with genuine consumer traction making a calculated move.

How Oura Got Here

Founded in 2013 in Oulu, Finland, Oura spent years fighting skepticism about whether a ring could be taken seriously as a health monitoring device. That changed fast when the NBA used Oura rings during its COVID bubble in 2020, catapulting the brand into mainstream awareness overnight. Since then, the company has secured backing from Alphabet and steadily expanded its health tracking features, building a loyal subscriber base in the process.

The Key Facts and Numbers

Oura confirmed in September 2024 that it has sold 5.5 million smart rings since launch — a number that validates the category and gives the company a strong story to tell investors. The company has filed its S-1 with the SEC, the standard document that kicks off the IPO process in the United States. Valuation details haven't been disclosed yet, but industry sources suggest Oura could target a multi-billion dollar market cap. The timing is deliberate: consumer interest in health wearables is at an all-time high.

What This Really Means

An Oura IPO is a statement of confidence for the entire health wearables category: there's a real market, users are paying monthly subscriptions, and the underlying data is something investors actually want a piece of. The company most under pressure here is arguably Apple — its Apple Watch dominates wearables broadly, but Apple has no answer in the smart ring space, and Oura works seamlessly with both iOS and Android. A strong debut from Oura signals that the ring isn't a niche curiosity; it's a platform.

What Happens Next for the Industry

How markets receive this IPO will set the tone for health hardware investment appetite heading into 2025. A successful listing makes it significantly easier for companies like Samsung — already in the ring space with its Galaxy Ring — and emerging startups to raise capital and scale. It may also accelerate consolidation: a publicly traded Oura with a defined market price becomes a much more straightforward acquisition target for any big tech player looking to buy its way into health data.

The real question worth watching: can a single product category sustain a public company long-term, or will Oura need to broaden its hardware lineup to justify whatever valuation the market assigns it?

Source: TechCrunch